Sanofi has joined the US investment bandwagon, announcing plans to invest at least $20bn in the country through 2030. The French group said the new funding will significantly increase its R&D spending there and direct billions of dollars toward domestic manufacturing.
Key Takeaways
- Sanofi to invest $20bn in US R&D and manufacturing by 2030.
The company noted it is also preparing for the potential launch of numerous new first- or best-in-class medicines across multiple...